What role might cardioneuroablation strategy have in syncope guidelines?

Vasovagal syncope (VVS) is the most common type of syncope. Although it is not related to an increase in mortality, recurrent syncope episodes may be disabling and reduce the quality of life. There are no optimal treatment strategies currently available, especially for the cardioinhibitory type of V...

Full description

Saved in:
Bibliographic Details
Published in:Türk Kardiyoloji Derneği arşivi 2019-01, Vol.47 (1), p.69-79
Main Authors: Tolga Aksu, Tümer Erdem Güler, Serdar Bozyel, Kıvanç Yalın
Format: Article
Language:English
Subjects:
bradycardia
fat pads
ganglionated plexi
parasympathetic
vagal ganglia
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vasovagal syncope (VVS) is the most common type of syncope. Although it is not related to an increase in mortality, recurrent syncope episodes may be disabling and reduce the quality of life. There are no optimal treatment strategies currently available, especially for the cardioinhibitory type of VVS. Cardioneuroablation (CNA) is a relatively novel technique that aims to eliminate vagal efferent output during VVS. The objective of this review was to explore the potential role of CNA strategy in syncope guidelines.
ISSN:1016-5169
DOI:10.5543/tkda.2018.10187